Latest filing published 16 Aug 2023 for Surgalign Holdings, INC., €162.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Terry M. Rich (chief executive) discloses dealings in Surgalign Holdings, Inc. to SEC (Form 4). Over a trading history stretching from 12 January 2020 to 15 August 2023, the count stands at 21 filings.
On the market, this insider has only ever bought: 5 purchases, €2.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 16 share grants.
Half of the purchases are above €293k and half below. Clusters matter here: 5 out of 5 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 16 August 2023, the filings show a share grant worth €162 in Surgalign Holdings, Inc. The last purchase on record was published on 16 February 2022, which is 1,711 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations